2010-02-04
Orphan Drug Designation for Elafin in the Treatment of Oesophagus Carcinoma
2009-09-23
Phase II clinical trial with Elafin for cardiovascular disease – University of Edinburgh and Proteo sign agreement
2009-02-17
Clinical study in Harvard reveals Elafin deficiency in acute respiratory distress syndrome (ARDS)
2008-12-10
Approval for a Phase II clinical trial with Elafin in kidney transplantation
2008-11-17
Start of the Phase II clinical trial with Elafin
2008-09-02
Proteo receives approval for Phase II clinical trial
2008-06-24
Proteo, Inc. also traded on the Berlin Stock Exchange
2008-06-11
Placement of Preferred Stock Series A – US$ 3.6 million finance for clinical trials
2008-01-25
Preclinical studies on pulmonary arterial hypertension – Proteo cooperates with Stanford University, USA
2007-08-09
Proteo Biotech, Germany and Minapharm, Egypt enter into development and license agreement for Elafin
